 |
| This division
offers to clinicians and clinical researchers laboratory services based on genomics,
proteomics, molecular cytogenetics, immunocytometry and immunohistochemistry for
metastasis risk investigation in cancer patients. The following parameters are
provided as complementary prognostic information on the unique molecular characteristics
of the patient´s tumor: |
 |
Proangiogenic activity index. |
|
Occult cancer cell dissemination index. |
|
Metastasis Recurrence Index. |
|
Prometastatic phenotype expression profiling. |
